{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:22:46Z","timestamp":1763400166198,"version":"3.37.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge"},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["UID\/MULTI\/04046\/2019","SFRH\/BD\/52495\/2014"],"award-info":[{"award-number":["UID\/MULTI\/04046\/2019","SFRH\/BD\/52495\/2014"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["PD\/BD\/142898\/2018"],"award-info":[{"award-number":["PD\/BD\/142898\/2018"]}]},{"name":"Instituto Nacional de Sa\u00fade Dr. Ricardo Jorge"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>DIS3L2 degrades different types of RNAs in an exosome-independent manner including mRNAs and several types of non-coding RNAs. DIS3L2-mediated degradation is preceded by the addition of nontemplated uridines at the 3\u2019end of its targets by the terminal uridylyl transferases 4 and 7. Most of the literature that concerns DIS3L2 characterizes its involvement in several RNA degradation pathways, however, there is some evidence that its dysregulated activity may contribute to cancer development. In the present study, we characterize the role of DIS3L2 in human colorectal cancer (CRC). Using the public RNA datasets from The Cancer Genome Atlas (TCGA), we found higher DIS3L2 mRNA levels in CRC tissues versus normal colonic samples as well as worse prognosis in patients with high DIS3L2 expression. In addition, our RNA deep-sequencing data revealed that knockdown (KD) of DIS3L2 induces a strong transcriptomic disturbance in SW480 CRC cells. Moreover, gene ontology (GO) analysis of significant upregulated transcripts displays enrichment in mRNAs encoding proteins involved in cell cycle regulation and cancer-related pathways, which guided us to evaluate which specific hallmarks of cancer are differentially regulated by DIS3L2. To do so, we employed four CRC cell lines (HCT116, SW480, Caco-2 and HT-29) differing in their mutational background and oncogenicity. We demonstrate that depletion of DIS3L2 results in reduced cell viability of highly oncogenic SW480 and HCT116 CRC cells, but had little or no impact in the more differentiated Caco-2 and HT-29 cells. Remarkably, the mTOR signaling pathway, crucial for cell survival and growth, is downregulated after DIS3L2 KD, whereas AZGP1, an mTOR pathway inhibitor, is upregulated. Furthermore, our results indicate that depletion of DIS3L2 disturbs metastasis-associated properties, such as cell migration and invasion, only in highly oncogenic CRC cells. Our work reveals for the first time a role for DIS3L2 in sustaining CRC cell proliferation and provides evidence that this ribonuclease is required to support the viability and invasive behavior of dedifferentiated CRC cells.<\/jats:p>","DOI":"10.1007\/s00018-023-04833-5","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T18:01:51Z","timestamp":1687284111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathway"],"prefix":"10.1007","volume":"80","author":[{"given":"Juan F.","family":"Garc\u00eda-Moreno","sequence":"first","affiliation":[]},{"given":"Rafaela","family":"Lacerda","sequence":"additional","affiliation":[]},{"given":"Paulo J.","family":"da Costa","sequence":"additional","affiliation":[]},{"given":"Marcelo","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Gama-Carvalho","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Matos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-5287","authenticated-orcid":false,"given":"Lu\u00edsa","family":"Rom\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"4833_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ng.1071","volume":"44","author":"D Astuti","year":"2012","unstructured":"Astuti D, Morris MR, Cooper WN et al (2012) Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet 44:277\u2013284. https:\/\/doi.org\/10.1038\/ng.1071","journal-title":"Nat Genet"},{"key":"4833_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq295","author":"M Mamolen","year":"2010","unstructured":"Mamolen M, Smith A, Andrulis ED (2010) Drosophila melanogaster Dis3 N-terminal domains are required for ribonuclease activities, nuclear localization and exosome interactions. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkq295","journal-title":"Nucleic Acids Res"},{"key":"4833_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1528","author":"D Schaeffer","year":"2009","unstructured":"Schaeffer D, Tsanova B, Barbas A et al (2009) The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities. Nat Struct Mol Biol. https:\/\/doi.org\/10.1038\/nsmb.1528","journal-title":"Nat Struct Mol Biol"},{"key":"4833_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn1020","author":"C Schneider","year":"2009","unstructured":"Schneider C, Leung E, Brown J, Tollervey D (2009) The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkn1020","journal-title":"Nucleic Acids Res"},{"key":"4833_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2013.63","author":"M Malecki","year":"2013","unstructured":"Malecki M, Viegas SC, Carneiro T et al (2013) The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway. EMBO J. https:\/\/doi.org\/10.1038\/emboj.2013.63","journal-title":"EMBO J"},{"key":"4833_CR6","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/emboj.2013.135","volume":"32","author":"M Lubas","year":"2013","unstructured":"Lubas M, Damgaard CK, Tomecki R et al (2013) Exonuclease hDIS3L2 specifies an exosome-independent 3\u2032-5\u2032 degradation pathway of human cytoplasmic mRNA. EMBO J 32:1855\u20131868. https:\/\/doi.org\/10.1038\/emboj.2013.135","journal-title":"EMBO J"},{"key":"4833_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41594-018-0132-7","volume":"25","author":"T Kurosaki","year":"2018","unstructured":"Kurosaki T, Miyoshi K, Myers JR, Maquat LE (2018) NMD-degradome sequencing reveals ribosome-bound intermediates with 3\u2032-end non-templated nucleotides. Nat Struct Mol Biol 25:940\u2013950. https:\/\/doi.org\/10.1038\/s41594-018-0132-7","journal-title":"Nat Struct Mol Biol"},{"key":"4833_CR8","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1261\/rna.040055.113","volume":"19","author":"D Ustianenko","year":"2013","unstructured":"Ustianenko D, Hrossova D, Potesil D et al (2013) Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs. RNA 19:1632\u20131638. https:\/\/doi.org\/10.1261\/rna.040055.113","journal-title":"RNA"},{"key":"4833_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbrc.2019.08.105","volume":"518","author":"PJ da Costa","year":"2019","unstructured":"da Costa PJ, Menezes J, Saramago M et al (2019) A role for DIS3L2 over natural nonsense-mediated mRNA decay targets in human cells. Biochem Biophys Res Commun 518:664\u2013671. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.105","journal-title":"Biochem Biophys Res Commun"},{"key":"4833_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature12119","volume":"497","author":"HM Chang","year":"2013","unstructured":"Chang HM, Triboulet R, Thornton JE, Gregory RI (2013) A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway. Nature 497:244\u2013248. https:\/\/doi.org\/10.1038\/nature12119","journal-title":"Nature"},{"key":"4833_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066048","author":"E Tassano","year":"2013","unstructured":"Tassano E, Buttgereit J, Bader M et al (2013) Genotype-phenotype correlation of 2q37 deletions including NPPC gene associated with skeletal malformations. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0066048","journal-title":"PLoS ONE"},{"key":"4833_CR12","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1080\/15476286.2016.1232238","volume":"13","author":"BP Towler","year":"2016","unstructured":"Towler BP, Jones CI, Harper KL et al (2016) A novel role for the 3\u2032-5\u2032 exoribonuclease Dis3L2 in controlling cell proliferation and tissue growth. RNA Biol 13:1286\u20131299. https:\/\/doi.org\/10.1080\/15476286.2016.1232238","journal-title":"RNA Biol"},{"key":"4833_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.04.026","author":"MP Thomas","year":"2015","unstructured":"Thomas MP, Liu X, Whangbo J et al (2015) Apoptosis triggers specific, rapid, and global mRNA decay with 3\u2032 uridylated intermediates degraded by DIS3L2. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2015.04.026","journal-title":"Cell Rep"},{"key":"4833_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1009297","volume":"16","author":"BP Towler","year":"2020","unstructured":"Towler BP, Pashler AL, Haime HJ et al (2020) Dis3L2 regulates cell proliferation and tissue growth though a conserved mechanism. PLoS Genet 16:1\u201329. https:\/\/doi.org\/10.1371\/journal.pgen.1009297","journal-title":"PLoS Genet"},{"key":"4833_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1101\/gad.315804.118","volume":"32","author":"RW Hunter","year":"2018","unstructured":"Hunter RW, Liu Y, Manjunath H et al (2018) Loss of Dis3l2 partially phenocopies Perlman syndrome in mice and results in upregulation of Igf2 in nephron progenitor cells. Genes Dev 32:903\u2013908. https:\/\/doi.org\/10.1101\/gad.315804.118","journal-title":"Genes Dev"},{"key":"4833_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43772","author":"Q Hu","year":"2011","unstructured":"Hu Q, Gao F, Tian W et al (2011) Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1\/2 phosphorylation. J Clin Investig. https:\/\/doi.org\/10.1172\/JCI43772","journal-title":"J Clin Investig"},{"key":"4833_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature13553","volume":"514","author":"CR Faehnle","year":"2014","unstructured":"Faehnle CR, Walleshauser J, Joshua-Tor L (2014) Mechanism of Dis3l2 substrate recognition in the Lin28-let-7 pathway. Nature 514:252\u2013256. https:\/\/doi.org\/10.1038\/nature13553","journal-title":"Nature"},{"key":"4833_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12721","author":"HI Suzuki","year":"2015","unstructured":"Suzuki HI, Katsura A, Miyazono K (2015) A role of uridylation pathway for blockade of let-7 microRNA biogenesis by Lin28B. Cancer Sci. https:\/\/doi.org\/10.1111\/cas.12721","journal-title":"Cancer Sci"},{"key":"4833_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1909","author":"HM Chang","year":"2012","unstructured":"Chang HM, Martinez NJ, Thornton JE et al (2012) Trim71 cooperates with microRNAs to repress Cdkn1a expression and promote embryonic stem cell proliferation. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms1909","journal-title":"Nat Commun"},{"key":"4833_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1151526","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science (1979). https:\/\/doi.org\/10.1126\/science.1151526","journal-title":"Science (1979)"},{"key":"4833_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.10.039","author":"E Piskounova","year":"2011","unstructured":"Piskounova E, Polytarchou C, Thornton JE et al (2011) Lin28A and Lin28B inhibit let-7 MicroRNA biogenesis by distinct mechanisms. Cell. https:\/\/doi.org\/10.1016\/j.cell.2011.10.039","journal-title":"Cell"},{"key":"4833_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ng.392","author":"SR Viswanathan","year":"2009","unstructured":"Viswanathan SR, Powers JT, Einhorn W et al (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. https:\/\/doi.org\/10.1038\/ng.392","journal-title":"Nat Genet"},{"key":"4833_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2017.00031","volume":"8","author":"J Balzeau","year":"2017","unstructured":"Balzeau J, Menezes MR, Cao S, Hagan JP (2017) The LIN28\/let-7 pathway in cancer. Front Genet 8:1\u201316. https:\/\/doi.org\/10.3389\/fgene.2017.00031","journal-title":"Front Genet"},{"key":"4833_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","volume":"18","author":"S Roush","year":"2008","unstructured":"Roush S, Slack FJ (2008) The let-7 family of microRNAs. Trends Cell Biol 18:505\u2013516. https:\/\/doi.org\/10.1016\/j.tcb.2008.07.007","journal-title":"Trends Cell Biol"},{"key":"4833_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tcb.2012.06.001","volume":"22","author":"JE Thornton","year":"2012","unstructured":"Thornton JE, Gregory RI (2012) How does Lin28 let-7 control development and disease? Trends Cell Biol 22:474\u2013482. https:\/\/doi.org\/10.1016\/j.tcb.2012.06.001","journal-title":"Trends Cell Biol"},{"key":"4833_CR26","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1158\/0008-5472.CAN-19-0376","volume":"79","author":"S Xing","year":"2019","unstructured":"Xing S, Li Z, Ma W et al (2019) DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing. Cancer Res 79:4923\u20134936. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0376","journal-title":"Cancer Res"},{"key":"4833_CR27","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01627","author":"S Wang","year":"2019","unstructured":"Wang S, Liu X (2019) The UCSCXenaTools R package: a toolkit for accessing genomics data from UCSC Xena platform, from cancer multi-omics to single-cell RNA-seq. J Open Source Softw. https:\/\/doi.org\/10.21105\/joss.01627","journal-title":"J Open Source Softw"},{"key":"4833_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7447.1073","author":"JM Bland","year":"2004","unstructured":"Bland JM, Altman DG (2004) The logrank test. BMJ. https:\/\/doi.org\/10.1136\/bmj.328.7447.1073","journal-title":"BMJ"},{"key":"4833_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT\u2013PCR. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"key":"4833_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00043","author":"AJ Amaral","year":"2014","unstructured":"Amaral AJ, Brito FF, Chobanyan T et al (2014) Quality assessment and control of tissue specific RNA-seq libraries of drosophila transgenic RNAi models. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2014.00043","journal-title":"Front Genet"},{"key":"4833_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu170","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"key":"4833_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"4833_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:1\u201321. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"4833_CR34","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"key":"4833_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc: Ser B (Methodol). https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Royal Stat Soc: Ser B (Methodol)"},{"key":"4833_CR36","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.15252\/embj.201695164","volume":"35","author":"MM Reim\u00e3o-Pinto","year":"2016","unstructured":"Reim\u00e3o-Pinto MM, Manzenreither RA, Burkard TR et al (2016) Molecular basis for cytoplasmic RNA surveillance by uridylation-triggered decay in Drosophila. EMBO J 35:2417\u20132434. https:\/\/doi.org\/10.15252\/embj.201695164","journal-title":"EMBO J"},{"key":"4833_CR37","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1093\/nar\/gkw649","volume":"44","author":"A \u0141abno","year":"2016","unstructured":"\u0141abno A, Warkocki Z, Kul\u00ednski T et al (2016) Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs. Nucleic Acids Res 44:10437\u201310453. https:\/\/doi.org\/10.1093\/nar\/gkw649","journal-title":"Nucleic Acids Res"},{"key":"4833_CR38","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.15252\/embj.201694857","volume":"35","author":"D Ustianenko","year":"2016","unstructured":"Ustianenko D, Pasulka J, Feketova Z et al (2016) TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. EMBO J 35:2179\u20132191. https:\/\/doi.org\/10.15252\/embj.201694857","journal-title":"EMBO J"},{"key":"4833_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2012.06.038","author":"G Ikonomou","year":"2012","unstructured":"Ikonomou G, Kostourou V, Shirasawa S et al (2012) Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation. J Proteom. https:\/\/doi.org\/10.1016\/j.jprot.2012.06.038","journal-title":"J Proteom"},{"key":"4833_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","volume":"21","author":"Y Sambuy","year":"2005","unstructured":"Sambuy Y, De Angelis I, Ranaldi G et al (2005) The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21:1\u201326. https:\/\/doi.org\/10.1007\/s10565-005-0085-6","journal-title":"Cell Biol Toxicol"},{"key":"4833_CR41","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.4206","author":"A Olejniczak","year":"2018","unstructured":"Olejniczak A, Szary\u0144ska M, Kmie\u0107 Z (2018) In vitro characterization of spheres derived from colorectal cancer cell lines. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2017.4206","journal-title":"Int J Oncol"},{"key":"4833_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915135107","author":"TM Yeung","year":"2010","unstructured":"Yeung TM, Gandhi SC, Wilding JL et al (2010) Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.0915135107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4833_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00396-1","volume":"10","author":"Z Zou","year":"2020","unstructured":"Zou Z, Tao T, Li H, Zhu X (2020) MTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci 10:1\u201311. https:\/\/doi.org\/10.1186\/s13578-020-00396-1","journal-title":"Cell Biosci"},{"key":"4833_CR44","doi-asserted-by":"publisher","DOI":"10.4149\/gpb_2019061","author":"W Yu","year":"2020","unstructured":"Yu W, Ling J, Yu H et al (2020) AZGP1 suppresses the process of colorectal cancer after upregulating FASN expression via mTOR signal pathway. Gen Physiol Biophys. https:\/\/doi.org\/10.4149\/gpb_2019061","journal-title":"Gen Physiol Biophys"},{"key":"4833_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117117","author":"W Li","year":"2020","unstructured":"Li W, Liu J (2020) Overexpression of the zinc-\u03b12-glycoprotein accelerates apoptosis and inhibits growth via the mTOR\/PTEN signaling pathway in gastric carcinoma cells. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2019.117117","journal-title":"Life Sci"},{"key":"4833_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00432-015-2000-8","volume":"142","author":"L Chang","year":"2016","unstructured":"Chang L, Wu P, Senthilkumar R et al (2016) Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway. J Cancer Res Clin Oncol 142:59\u201372. https:\/\/doi.org\/10.1007\/s00432-015-2000-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"15","key":"4833_CR47","first-page":"3581","volume":"59","author":"M Grewe","year":"1999","unstructured":"Grewe M, Gansauge F, Schmid RM et al (1999) Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70(s6K) pathway in human pancreatic cancer cells. Cancer Res 59(15):3581\u20133587","journal-title":"Cancer Res"},{"key":"4833_CR48","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-860-9:015","author":"HC Chen","year":"2005","unstructured":"Chen HC (2005) Boyden chamber assay. Methods Mol Biol. https:\/\/doi.org\/10.1385\/1-59259-860-9:015","journal-title":"Methods Mol Biol"},{"key":"4833_CR49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.115.3.453","author":"S Boyden","year":"1962","unstructured":"Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. https:\/\/doi.org\/10.1084\/jem.115.3.453","journal-title":"J Exp Med"},{"key":"4833_CR50","first-page":"391","volume-title":"Biotechnology annual review","author":"SA Eccles","year":"2005","unstructured":"Eccles SA, Box C, Court W (2005) Cell migration\/invasion assays and their application in cancer drug discovery. Biotechnology annual review. Elsevier, pp 391\u2013421"},{"key":"4833_CR51","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2016.12.011","author":"J Hartke","year":"2017","unstructured":"Hartke J, Johnson M, Ghabril M (2017) The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. https:\/\/doi.org\/10.1053\/j.semdp.2016.12.011","journal-title":"Semin Diagn Pathol"},{"key":"4833_CR52","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1101\/gad.1098503R","volume":"17","author":"I Grummt","year":"2003","unstructured":"Grummt I (2003) Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev 17:1691\u20131702. https:\/\/doi.org\/10.1101\/gad.1098503R","journal-title":"Genes Dev"},{"key":"4833_CR53","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1158\/0008-5472.CAN-11-3992","volume":"72","author":"G Donati","year":"2012","unstructured":"Donati G, Montanaro L, Derenzini M (2012) Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res 72:1602\u20131607. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3992","journal-title":"Cancer Res"},{"key":"4833_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10100-8","author":"V Prakash","year":"2019","unstructured":"Prakash V, Carson BB, Feenstra JM et al (2019) Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-10100-8","journal-title":"Nat Commun"},{"key":"4833_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-96","author":"M Schneider","year":"2012","unstructured":"Schneider M, Huber J, Hadaschik B et al (2012) Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. BMC Cancer. https:\/\/doi.org\/10.1186\/1471-2407-12-96","journal-title":"BMC Cancer"},{"key":"4833_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690790","author":"NJ De Both","year":"1999","unstructured":"De Both NJ, Vermey M, Dinjens WN, Bosman FT (1999) A comparative evaluation of various invasion assays testing colon carcinoma cell lines. Br J Cancer. https:\/\/doi.org\/10.1038\/sj.bjc.6690790","journal-title":"Br J Cancer"},{"key":"4833_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.09.014","author":"I Heo","year":"2008","unstructured":"Heo I, Joo C, Cho J et al (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell. https:\/\/doi.org\/10.1016\/j.molcel.2008.09.014","journal-title":"Mol Cell"},{"key":"4833_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.08.002","author":"I Heo","year":"2009","unstructured":"Heo I, Joo C, Kim YK et al (2009) TUT4 in concert with Lin28 suppresses MicroRNA biogenesis through Pre-MicroRNA uridylation. Cell. https:\/\/doi.org\/10.1016\/j.cell.2009.08.002","journal-title":"Cell"},{"key":"4833_CR59","doi-asserted-by":"publisher","DOI":"10.1261\/rna.034538.112","author":"JE Thornton","year":"2012","unstructured":"Thornton JE, Chang HM, Piskounova E, Gregory RI (2012) Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7). RNA. https:\/\/doi.org\/10.1261\/rna.034538.112","journal-title":"RNA"},{"key":"4833_CR60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0189","author":"T Decker","year":"2003","unstructured":"Decker T, Hipp S, Ringshausen I et al (2003) Rapamycin-induced g1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood. https:\/\/doi.org\/10.1182\/blood-2002-01-0189","journal-title":"Blood"},{"key":"4833_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.04.027","author":"F Hong","year":"2008","unstructured":"Hong F, Larrea MD, Doughty C et al (2008) mTOR-Raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell. https:\/\/doi.org\/10.1016\/j.molcel.2008.04.027","journal-title":"Mol Cell"},{"key":"4833_CR62","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen DX, Bos PD, Massagu\u00e9 J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274\u2013284. https:\/\/doi.org\/10.1038\/nrc2622","journal-title":"Nat Rev Cancer"},{"key":"4833_CR63","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.addr.2011.04.008","volume":"63","author":"TD Palmer","year":"2011","unstructured":"Palmer TD, Ashby WJ, Lewis JD, Zijlstra A (2011) Targeting tumor cell motility to prevent metastasis. Adv Drug Deliv Rev 63:568\u2013581. https:\/\/doi.org\/10.1016\/j.addr.2011.04.008","journal-title":"Adv Drug Deliv Rev"},{"key":"4833_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-7388-0","author":"EA McSherry","year":"2007","unstructured":"McSherry EA, Donatello S, Hopkins AM, McDonnell S (2007) Molecular basis of invasion in breast cancer. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-007-7388-0","journal-title":"Cell Mol Life Sci"},{"key":"4833_CR65","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrc1231","volume":"3","author":"J Condeelis","year":"2003","unstructured":"Condeelis J, Segall JE (2003) Intravital imaging of cell movement in tumours. Nat Rev Cancer 3:921\u2013930. https:\/\/doi.org\/10.1038\/nrc1231","journal-title":"Nat Rev Cancer"},{"key":"4833_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jss.2007.12.757","volume":"149","author":"B Farrow","year":"2008","unstructured":"Farrow B, Albo D, Berger DH (2008) The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res 149:319\u2013328. https:\/\/doi.org\/10.1016\/j.jss.2007.12.757","journal-title":"J Surg Res"},{"issue":"3","key":"4833_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cytogfr.2015.01.002","volume":"26","author":"J Brouwer-Visser","year":"2015","unstructured":"Brouwer-Visser J, Huang GS (2015) IGF2 signaling and regulation in cancer. Cytokine Growth Factor Rev 26(3):371\u2013377","journal-title":"Cytokine Growth Factor Rev"},{"key":"4833_CR68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/biomedicines11010229","volume":"11","author":"A Belfiore","year":"2023","unstructured":"Belfiore A, Rapicavoli RV, Le Moli R et al (2023) IGF2: a role in metastasis and tumor evasion from immune surveillance? Biomedicines 11:229. https:\/\/doi.org\/10.3390\/biomedicines11010229","journal-title":"Biomedicines"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04833-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-04833-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04833-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T21:03:56Z","timestamp":1689023036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-04833-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-04833-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"type":"print","value":"1420-682X"},{"type":"electronic","value":"1420-9071"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"185"}}